1036260-43-1 | Cis-3-aminocyclobutanol

Packsize	Purity	Availability	Price	Discounted Price
250mg	96%	in stock	$297.00	$208.00
1g	96%	in stock	$712.00	$498.00
5g	96%	in stock	$2,499.00	$1,749.00

Description

• Catalog Number: AD80287
• Chemical Name: Cis-3-aminocyclobutanol
• CAS Number: 1036260-43-1
• Molecular Formula: C4H9NO
• Molecular Weight: 87.1204
• MDL Number: MFCD09029034
• SMILES: N[C@@H]1C[C@@H](C1)O

Computed Properties

• Complexity: 49.5
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 6
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -0.8

Upstream Synthesis Route

Cis-3-Aminocyclobutan-1-ol is a versatile compound that finds wide application in chemical synthesis. This unique molecule, with its cyclic structure and amino group, serves as a valuable building block in the creation of various organic compounds.One of the key uses of cis-3-Aminocyclobutan-1-ol in chemical synthesis is as a starting material for the preparation of heterocyclic compounds. By leveraging the reactivity of the amino group and the cyclic nature of the molecule, chemists can efficiently construct complex structures with diverse functionalities. This compound can participate in a range of reactions, including ring-opening reactions, acylation, alkylation, and cyclization, enabling the synthesis of a wide variety of organic molecules.Additionally, cis-3-Aminocyclobutan-1-ol can serve as a chiral building block in asymmetric synthesis. Its inherent chirality can be exploited to introduce stereochemistry into the final products, making it a valuable tool for the preparation of enantioenriched compounds. Chemists can utilize this compound in conjunction with other chiral reagents or catalysts to achieve high levels of stereocontrol in their synthesis processes.Overall, cis-3-Aminocyclobutan-1-ol plays a crucial role in the realm of chemical synthesis, offering chemists a powerful tool for the construction of complex organic molecules with diverse structures and functionalities.

Literature

• Stereoselective synthesis of cis-1,3-disubstituted cyclobutyl kinase inhibitors.

  Organic letters 20040527